Our experimental results showed that after drug withdrawal, microvascular densities in tumor tissues in the bevacizumab, recombinant human endostatin and combined drug groups, containing antiangiogenic drugs, were lower than those of control animals and the EGFR‐TKI group alone. This evidence concerns the gene COL18A1 and neoplasm.